Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)

CNY 8.65

(0.7%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.91 Billion 1.84 Billion 1.52 Billion 1.53 Billion 1.08 Billion 984.31 Million
Total Current Assets 636.42 Million 613.99 Million 586.82 Million 812.88 Million 590.05 Million 628.29 Million
Cash And Short Term Investments 138.33 Million 100.77 Million 152.47 Million 448.08 Million 181.65 Million 139.24 Million
Cash and Cash Equivalents 138.23 Million 100.66 Million 72.47 Million 330.08 Million 181.65 Million 139.24 Million
Short Term Investments 94.33 Thousand 111.57 Thousand 80 Million 118 Million - 141.23 Million
Net Receivables 306.74 Million 318.91 Million 314.28 Million 274.63 Million 304.2 Million 265.19 Million
Inventory 184.33 Million 183.34 Million 118.77 Million 86.82 Million 94.03 Million 82.21 Million
Other Current Assets 7.02 Million 10.95 Million 1.29 Million 3.33 Million 10.16 Million 141.63 Million
Total Non-Current Assets 1.27 Billion 1.22 Billion 937.59 Million 723.05 Million 493.58 Million 356.01 Million
Net PPE 706.29 Million 593.74 Million 463.94 Million 381.08 Million 356.56 Million 250.56 Million
Good Will And Intangible Assets 165.04 Million 149.15 Million 137.69 Million 131.94 Million 117.77 Million 89.84 Million
Good Will - - - - - -
Intangible Assets 165.04 Million 149.15 Million 137.69 Million 131.94 Million 117.77 Million 89.84 Million
Long-Term Investments 383.17 Million 461.46 Million 232.5 Million 65.64 Million 3.93 Million 2.00
Tax Assets 10.32 Million 14.44 Million 11.26 Million 12.59 Million 8.34 Million 4.39 Million
Other Non Current Assets 10.52 Million 11.05 Million 92.2 Million 131.77 Million 6.96 Million 11.2 Million
Other Assets - 1.00 1.00 - - -
Total Liabilities 798.46 Million 714.64 Million 633.98 Million 707.63 Million 374.88 Million 323.72 Million
Total Current Liabilities 555.42 Million 498.75 Million 441.23 Million 513.63 Million 332.69 Million 298.81 Million
Account Payables 105.07 Million 95.66 Million 64.89 Million 44.81 Million 30.77 Million 42.35 Million
Tax Payables 8.88 Million 5.93 Million 16.88 Million 11.56 Million 11.63 Million 12.78 Million
Short Term Debt 397.11 Million 323.77 Million 268.34 Million 404.48 Million 238.27 Million 209.05 Million
Deferred Revenue 53.1 Million 13.85 Million 107.64 Million 63.83 Million 59.42 Million 2.00
Other Current Liabilities 130.13 Thousand 65.45 Million 348.81 Thousand 509.77 Thousand 4.22 Million 47.4 Million
Total Non Current Liabilities 243.04 Million 215.89 Million 192.74 Million 193.99 Million 42.19 Million 24.9 Million
Long-Term Debt 204.89 Million 162.4 Million 161.44 Million 159.94 Million 16.19 Million 3.72 Million
Deferred Revenue Non Current 20.83 Million 22.14 Million 24.51 Million 23.99 Million 22.39 Million 21.18 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 588.69 Thousand 3.35 Million 3.41 Million 3.5 Million 16.19 Million 3.72 Million
Other Liabilities - 1.00 - 1.00 1.00 -
Total Equity 1.11 Billion 1.12 Billion 890.44 Million 828.29 Million 708.75 Million 660.58 Million
Stock Holders Equity 1.11 Billion 1.12 Billion 890.44 Million 828.29 Million 707.44 Million 658.71 Million
Common Stock 231.49 Million 231.96 Million 164.04 Million 117.15 Million 117.09 Million 117.09 Million
Retained Earnings 543.56 Million 502.3 Million 417.24 Million 341.06 Million 287.3 Million 226.35 Million
Accumulated other comprehensive income 159.3 Million 221.32 Million 98.24 Million 125.49 Million 56.01 Million 51.32 Million
Common Stock Equity 1.11 Billion 1.12 Billion 890.44 Million 828.29 Million 707.44 Million 658.71 Million
Capital Lease Obligation 9.35 Million 5.72 Million 6.65 Million 7.64 Million - -
Total Investments 383.27 Million 461.57 Million 312.5 Million 183.64 Million 3.93 Million 2.00
Total Debt 602 Million 486.17 Million 429.78 Million 564.43 Million 254.47 Million 212.77 Million
Net Debt 463.77 Million 385.5 Million 357.3 Million 234.34 Million 72.81 Million 73.52 Million

Balance Sheet Charts